---
title: "002275.SZ (002275.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002275.SZ/news.md"
symbol: "002275.SZ"
name: "002275.SZ"
parent: "https://longbridge.com/en/quote/002275.SZ.md"
datetime: "2026-03-10T21:51:03.833Z"
locales:
  - [en](https://longbridge.com/en/quote/002275.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002275.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002275.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/002275.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/002275.SZ/news.md)


# 002275.SZ (002275.SZ) — Related News

### [China Post Securities: The pharmaceutical sector is experiencing a volatile upward trend, and there is still room for improvement in the market capitalization share of pharmaceutical stocks](https://longbridge.com/en/news/268005569.md)
*2025-12-01T02:54:02.000Z*
> China Post Securities released a research report stating that since the beginning of 2025, the pharmaceutical sector has

### [Guilin Sanjin released its performance for the first three quarters, with a net profit attributable to the parent company of 385 million yuan, a year-on-year increase of 0.35%](https://longbridge.com/en/news/263310253.md)
*2025-10-29T13:50:09.000Z*
> According to the Zhitong Finance APP, Guilin Sanjin released its third-quarter report for 2025. In the first three quart

### [Guilin Sanjin plans to distribute 118 million yuan in cash in the first three quarters of 2025](https://longbridge.com/en/news/263237145.md)
*2025-10-29T08:24:13.000Z*
> Guilin Sanjin announced that a board meeting will be held on October 28, 2025, to review the profit distribution plan fo

### [Guilin Sanjin provides an additional guarantee of 20 million yuan for its subsidiary Baochuan Biotechnology](https://longbridge.com/en/news/255912782.md)
*2025-09-04T08:39:41.000Z*
> Guilin Sanjin Pharmaceutical provided a guarantee of 20 million yuan to Baochuan Biotechnology, a wholly-owned subsidiar

### [](https://longbridge.com/en/news/251767636.md)
*2025-08-06T06:41:47.000Z*
> A-share pharmaceutical stocks continue to adjust, CheezhengTTM approaches the limit down, and multiple stocks such as Xi

### [The generic drug consistency evaluation sector has declined in the short term, with Guilin Sanjin falling over 6%](https://longbridge.com/en/news/251739486.md)
*2025-08-06T01:52:21.000Z*
> The generic drug consistency evaluation sector has declined in the short term, with Guilin Sanjin dropping over 6%, and 

### [Research Report Gold Mining | China Post Securities: Guilin Sanjin's profitability steadily improves, maintaining a "Buy" rating](https://longbridge.com/en/news/246954811.md)
*2025-07-02T09:31:54.000Z*
> China Post Securities research report points out that Guilin Sanjin's profitability is steadily improving, and the bioph

### [June Institutional Research: 902 Listed Companies Were Investigated, Popular Stocks' Reception Volume and Frequency Exposed](https://longbridge.com/en/news/246528923.md)
*2025-06-29T03:12:09.000Z*
> During June, 902 listed companies received institutional research, indicating the market's attention to potential invest

### [Global Dividend Stocks To Consider In June 2025](https://longbridge.com/en/news/243068796.md)
*2025-06-04T09:16:43.000Z*
> As global markets face trade policy complexities and inflation trends, dividend stocks remain appealing for steady incom